Cargando…
Amplification of the Melanocortin-1 Receptor in Nephrotic Syndrome Identifies a Target for Podocyte Cytoskeleton Stabilization
The melanocortin-1 receptor (MC1R) in podocytes has been suggested as the mediator of the ACTH renoprotective effect in patients with nephrotic syndrome with the mechanism of action beeing stabilization of the podocyte actin cytoskeleton. To understand how melanocortin receptors are regulated in nep...
Autores principales: | Bergwall, Lovisa, Wallentin, Hanna, Elvin, Johannes, Liu, Peidi, Boi, Roberto, Sihlbom, Carina, Hayes, Kyle, Wright, Dale, Haraldsson, Börje, Nyström, Jenny, Buvall, Lisa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6200758/ https://www.ncbi.nlm.nih.gov/pubmed/30356069 http://dx.doi.org/10.1038/s41598-018-34004-7 |
Ejemplares similares
-
Orellanine specifically targets renal clear cell carcinoma
por: Buvall, Lisa, et al.
Publicado: (2017) -
Effects of Melanocortin 1 Receptor Agonists in Experimental Nephropathies
por: Lindskog Jonsson, Annika, et al.
Publicado: (2014) -
Levamisole Modulation of Podocytes’ Actin Cytoskeleton in Nephrotic Syndrome
por: Veissi, Susan T., et al.
Publicado: (2023) -
Pharmacokinetic Properties of the Nephrotoxin Orellanine in Rats
por: Najar, Deman, et al.
Publicado: (2018) -
Mesangial cells from patients with IgA nephropathy have increased susceptibility to galactose-deficient IgA1
por: Ebefors, Kerstin, et al.
Publicado: (2016)